Enter assignee name

Forward Citations = 57

Loading Chart...

12 inventors (with patents filed for the assignee):

Yasuyuki Igarashi (5 out of 15 patents)

Sen-Itiroh Hakomori (3 out of 26 patents)

Sen-itiroh Hakomori (2 out of 25 patents)

4. Fuqiang Ruan (2 out of 3 patents)

5. Steven B Levery (1 out of 9 patents)

6. Edward D Nudelman (1 out of 17 patents)

7. Shigeyuki Kawa (1 out of 4 patents)

8. Yoshito Sadahira (1 out of 4 patents)

9. Khalid Sadozai (1 out of 2 patents)

10. Hideki Ohta (1 out of 1 patent)

11. Yutaka Yatomi (1 out of 1 patent)

12. Yong S Park (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 6031135 - Trimethylsphingosine derivatives (2000-02-29),

2. 5693620 - Plasmalopsychosines and plasmalocerebrosides (1997-12-02),

3. 5677189 - Method for quantifying sphingosine and for diagnosing platelet activation (1997-10-14),

4. 5663404 - Sphingosine-1-phosphate essentially free of L-threo isomer (1997-09-02),

5. 5627171 - Sphingosine-1-phosphate/trimethylsphingosine composition (1997-05-06),

Oncomembrane, Inc. is a biotechnology company focused on developing innovative cancer therapies. Our cutting-edge research and technology aim to revolutionize the way cancer is treated by targeting tumor cell membranes. Through our unique approach, we strive to improve patient outcomes and quality of life. Visit our website to learn more about our pipeline and breakthrough discoveries.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#339 in Seattle, WA

#1,190 in Washington

#50,165 in US

Seattle, WA, United States of America

Oncomembrane, Inc.